June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Nigeria's Kaduna pairs with Zipline for drone-delivered COVID vaccines

Published 03/02/2021, 12:29
Updated 03/02/2021, 12:30
© Reuters

By Libby George
LAGOS, Feb 3 (Reuters) - Nigeria's Kaduna state has signed a
deal with medical delivery firm Zipline that will allow drone
shipment of COVID-19 vaccines without significant state
investment in cold-chain storage, the company said on Wednesday.

Kaduna's partnership with Zipline, which delivered more than
1 million doses of other vaccines in Africa over the past year,
will also enable on-demand delivery of blood products,
medications and other vaccines.
"It will help ensure that millions of people in Kaduna State
will always get the care they need," Kaduna Governor Nasir
El-Rufai said.
Zipline said its end-to-end cold chain distribution
capability, which can safely deliver even the Pfizer vaccine,
would allow Kaduna health facilities to bypass purchases of
ultra-low freezers and enable on-demand deliveries of precise
amounts of COVID-19 vaccines.
The company said it is working with an unnamed "major
COVID-19 vaccine manufacturer" to enable access to COVID-19
vaccine deliveries in all the markets where it operates. It
currently offers drone delivery of blood, vaccines and other
medical equipment in Ghana, Rwanda and the United States.
Zipline is also in talks with other states in Nigeria.
Nations across Africa, with limited cold-chain storage and
poor road and rail networks, are grappling with how to deliver
COVID-19 vaccines that require ultra-low temperature storage.
The Pfizer vaccine must be stored at around -70 degrees
Celsius (-112°F) before being sent to distribution centres in
specially designed cool boxes filled with dry ice.
Nigeria has said it will seek vaccines that are less
dependent on cooling facilities.
Kaduna services are slated to begin in the second quarter,
with round-the-clock service from three distribution centres
with 30 drones each.
El-Rufai said Kaduna had also upgraded 255 primary health
centres, installed a pharmagrade warehouse and is recruiting and
training 3,000 officers to manage the facilities.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.